Advanced search
Publication Cover
Emerging Microbes & Infections Volume 4, 2015 - Issue 1
Submit an article Journal homepage
1,181
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains

Huayong LiuKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institute of Medical Microbiology and Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, Shanghai 200032, China
,
Yanfeng ZhaoDepartment of Laboratory Medicine, Affiliated Gulou Hospital, Medical College of Nanjing University, Nanjing 210008, Jiangsu, China
,
Dan ZhaoCollege of Biotechnology and Pharmaceutical Engineering, Nanjing University of Technology, Nanjing 210009, Jiangsu, China
,
Ting GongKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institute of Medical Microbiology and Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, Shanghai 200032, China
,
Youcong WuKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institute of Medical Microbiology and Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, Shanghai 200032, China
,
Haiyan HanKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institute of Medical Microbiology and Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, Shanghai 200032, China
,
Tao XuKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institute of Medical Microbiology and Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, Shanghai 200032, China
,
Andreas PeschelCellular and Molecular Microbiology Division, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany
,
Shiqing HanCollege of Biotechnology and Pharmaceutical Engineering, Nanjing University of Technology, Nanjing 210009, Jiangsu, China
&
Di QuKey Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institute of Medical Microbiology and Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, Shanghai 200032, China
 show all
Pages 1-6 | Received 03 Jun 2014, Accepted 24 Nov 2014, Published online: 25 Jan 2019

  • Manunga JJr, Olak J, Rivera C, Martin M.Prevalence of methicillin-resistant Staphylococcus aureus in elective surgical patients at a public teaching hospital: an analysis of 1039 patients. Am Surg2012;78: 1096–1099.
  • Haddadin AS, Fappiano SA, Lipsett PA.Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J2002;78: 385–392.
  • Morell EA, Balkin DM.Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development. Yale J Biol Med2010;83: 223–233.
  • Kateete DP, Namazzi S, Okee M et al.High prevalence of methicillin resistant Staphylococcus aureus in the surgical units of Mulago hospital in Kampala, Uganda. BMC Res Notes2011;4: 326.
  • Haaber J, Cohn MT, Frees D, Andersen TJ, Ingmer H.Planktonic aggregates of Staphylococcus aureus protect against common antibiotics. PloS One2012;7: e41075.
  • Otto M.Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med2013;64: 175–188.
  • Cue D, Lei MG, Lee CY.Genetic regulation of the intercellular adhesion locus in staphylococci. Front Cell Infect Microbiol2012;2: 38.
  • Mah TF, O’Toole GA.Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol2001;9: 34–39.
  • Lewis K.Riddle of biofilm resistance. Antimicrob Agents Chemother2001;45: 999–1007.
  • Hou W, Sun X, Wang Z, Zhang Y.Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections. Invest Ophthalmol Vis Sci2012;53: 5624–5631.
  • Darouiche RO.Treatment of infections associated with surgical implants. N Engl J Med2004;350: 1422–1429.
  • Walters MC 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS.Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother2003;47: 317–323.
  • Aendekerk S, Diggle SP, Song Z et al.The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. Microbiology2005;151(Pt 4): 1113–1125.
  • Dubrac S, Msadek T.Tearing down the wall: peptidoglycan metabolism and the WalK/WalR (YycG/YycF) essential two-component system. Adv Exp Med Biol2008;631: 214–228.
  • Dubrac S, Bisicchia P, Devine KM, Msadek T.A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway. Mol Microbiol2008;70: 1307–1322.
  • Okada A, Igarashi M, Okajima T et al.Walkmycin B targets WalK (YycG), a histidine kinase essential for bacterial cell growth. J Antibiot2010;63: 89–94.
  • Watanabe T, Hashimoto Y, Yamamoto K et al.Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus. J Antibiot2003;56: 1045–1052.
  • Yamamoto K, Kitayama T, Minagawa S et al.Antibacterial agents that inhibit histidine protein kinase YycG of Bacillus subtilis. Biosci Biotechnol Biochem2001;65: 2306–2310.
  • Hilliard JJ, Goldschmidt RM, Licata L, Baum EZ, Bush K.Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob Agents Chemother1999;43: 1693–1699.
  • Qin Z, Zhang J, Xu B et al.Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections. BMC Microbiol2006;6: 96.
  • Huang RZ, Zheng LK, Liu HY et al.Thiazolidione derivatives targeting the histidine kinase YycG are effective against both planktonic and biofilm-associated Staphylococcus epidermidis. Acta Pharmacol Sin2012;33: 418–425.
  • Pan B, Huang R, Zheng L et al.Thiazolidione derivatives as novel antibiofilm agents: design, synthesis, biological evaluation, and structure-activity relationships. Eur J Med Chem2011;46: 819–824.
  • Liu H, Zhao D, Chang J et al.Efficacy of novel antibacterial compounds targeting histidine kinase YycG protein. Appl Microbiol Biotechnol2014;98: 6003–6013.
  • Tenover FC, Tickler IA, Goering RV, Kreiswirth BN, Mediavilla JR, Persing DH.Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States Hospitals. Antimicrob Agents Chemother2012;56: 1324–1330.
  • O’Neill E, Pozzi C, Houston P et al.Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol2007;45: 1379–1388.
  • Stepanovic S, Vukovic D, Hola V et al.Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS2007;115: 891–899.
  • Jiang L, Wang F, Han F, Prinyawiwatkul W, No HK, Ge B.Evaluation of diffusion and dilution methods to determine the antimicrobial activity of water-soluble chitosan derivatives. J Appl Microbiol2013;114: 956–963.
  • Peterson JF, Pfaller MA, Diekema DJ, Rinaldi MG, Riebe KM, Ledeboer NA.Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp. J Clin Microbiol2011;49: 1765–1771.
  • Ning Y, Hu X, Ling J et al.Candida albicans survival and biofilm formation under starvation conditions. Int Endod J2013;46: 62–70.
  • Liduma I, Tracevska T, Bers U, Zilevica A.Phenotypic and genetic analysis of biofilm formation by Staphylococcus epidermidis. Medicina (Kaunas)2012;48: 305–309.
  • Olson ME, Ceri H, Morck DW, Buret AG, Read RR.Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res2002;66: 86–92.
  • Saginur R, Stdenis M, Ferris W et al.Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother2006;50: 55–61.
  • Elhani D. [Does the emergence of antibiotic resistance announce the return of the dark ages?] Ann Biol Clin (Paris)2011;69: 637–646.French.
  • Woodford N, Wareham DW;UK Antibacterial Antisense Study Group. Tackling antibiotic resistance: a dose of common antisense? J Antimicrob Chemother2009;63: 225–229.
  • Dubrac S, Boneca IG, Poupel O, Msadek T.New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J Bacteriol2007;189: 8257–8269.
  • Monzon M, Oteiza C, Leiva J, Amorena B.Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother2001;48: 793–801.
  • Kiedrowski MR, Horswill AR.New approaches for treating staphylococcal biofilm infections. Ann NY Acad Sci2011;1241: 104–121.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.